HQ Function

Served as the global headquarters, housing corporate offices, research and development laboratories, and administrative functions. It was central to Cubist's drug discovery, clinical development, and commercial strategy operations.

Notable Features:

State-of-the-art laboratory facilities designed for antibiotic research and development, part of the dynamic biotech ecosystem in the Greater Boston area.

Work Culture:

Known for a science-driven, innovative, and collaborative environment focused on tackling challenging infectious diseases. Employees were often mission-driven, aiming to bring life-saving therapies to patients.

HQ Significance:

The Lexington headquarters was the nerve center for Cubist's growth from a research-focused startup to a leading commercial-stage biopharmaceutical company in the anti-infectives space. Key strategic decisions and research breakthroughs originated here.

Values Reflected in HQ: Innovation in scientific research, a commitment to addressing unmet medical needs in infectious diseases, and a focus on patient care, particularly in acute and critical care settings.

Location:

Prior to its acquisition by Merck in 2015, Cubist Pharmaceuticals was actively expanding its global presence. This was primarily driven by the commercialization of its flagship antibiotic, Cubicin®, and later Sivextro™. Key functions supported globally included establishing and managing commercial operations in North America and Europe (via its Zurich international HQ), overseeing multi-regional clinical trials for its pipeline candidates, handling regulatory submissions to health authorities worldwide (e.g., FDA, EMA), and building sales, marketing, and medical affairs capabilities in targeted international markets.

Street Address:

65 Hayden Avenue

City:

Lexington

State/Province:

Massachusetts

Country:

U.S.A.